Genmab (GMAB) and AbbVie (ABBV) announce Epcoritamab in combination with R-CHOP demonstrates statistically significant improvement in Progression-Free Survival in Patients with newly diagnosed Diffuse Large B-Cell Lymphoma

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

Genmab (GMAB) and AbbVie (ABBV) announce Epcoritamab in combination with R-CHOP demonstrates statistically significant improvement in Progression-Free Survival in Patients with newly diagnosed Diffuse Large B-Cell Lymphoma

CRUDE WRAP: WTI (X6) SETTLES USD 1.68 LOWER AT 89.43/BBL

SpaceX (SPCX) is seeking approval to build a 32.4-mile natural gas pipeline in Florida to supply methane for Starship launches from Cape Canaveral

On the Newsquawk feed at , 20 minutes before this page.

Demo platformFree. No signup, no card.

Related headlines

The feed had this first.

Demo platform